144 related articles for article (PubMed ID: 9164143)
1. [Axonal Guillain-Barré syndrome associated with antibodies to Ga1NAc-GD1a and unidentified acidic glycolipids].
Ono M; Sakai T; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):119-22. PubMed ID: 9164143
[TBL] [Abstract][Full Text] [Related]
2. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
3. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
Yuki N; Yoshino H; Sato S; Shinozawa K; Miyatake T
Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
[TBL] [Abstract][Full Text] [Related]
4. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
5. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
7. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
[TBL] [Abstract][Full Text] [Related]
8. [A case of Guillain-Barré syndrome with bulbar palsy and a high titer of anti-GT1a antibody].
Hashiguchi S; Ogasawara N; Yoshino H
Rinsho Shinkeigaku; 1997 Apr; 37(4):331-3. PubMed ID: 9248344
[TBL] [Abstract][Full Text] [Related]
9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
10. [A case of pharyngeal-cervical-branchial variant of Guillain-Barré syndrome with IgG anti-GT1a antibody].
Nagano K; Koga M; Yuki N
Rinsho Shinkeigaku; 1998 Apr; 38(4):333-5. PubMed ID: 9742882
[TBL] [Abstract][Full Text] [Related]
11. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
12. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
[TBL] [Abstract][Full Text] [Related]
13. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
[TBL] [Abstract][Full Text] [Related]
14. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
[TBL] [Abstract][Full Text] [Related]
16. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
17. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
Kusunoki S; Chiba A; Kon K; Ando S; Arisawa K; Tate A; Kanazawa I
Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
[TBL] [Abstract][Full Text] [Related]
18. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
19. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
[TBL] [Abstract][Full Text] [Related]
20. [An autopsy case with lower motor neuron disease showing a transient-appearance of anti-GM1 antibody and an improvement of conduction block after gamma-globulin administration].
Kikuchi H; Kawano Y; Dohura K; Kawamura T; Taniwaki T; Yamada T; Kato M; Iwaki T; Kira J
No To Shinkei; 1999 May; 51(5):455-64. PubMed ID: 10396755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
